System and method for providing closed loop infusion formulation delivery

• US 8,784,369 B2
• Filed: 01/19/2011
• Issued: 07/22/2014
• Est. Priority Date: 09/07/2001
• Status: Active Grant

• Current Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Inventors: Starkweather, Timothy J., Lebel, Ronald J., Shah, Rajiv, Miller, Michael E.
• Primary Examiner(s): GILBERT, ANDREW M
• Application Number:
  US13/009,508
• Publication Number:
  US 20110112505A1
• Time in Patent Office: 1,280 Days
• Field of Search: 604/890.1, 604/891.1, 604/500, 604/503, 604/504, 604 65- 67, 604/131, 604/151, 600/316, 600/347, 600/365, 128/923
• US Class Current: 604/66
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/172 electrical or electronic A61M5/16804, A61M5/16831 take precedence
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

A system and method for providing closed loop infusion formulation delivery which accurately calculates a delivery amount based on a sensed biological state by adjusting an algorithm'"'"'s programmable control parameters. The algorithm calculates a delivery amount having proportional, derivative, and basal rate components. The control parameters may be adjusted in real time to compensate for changes in a sensed biological state that may result from daily events. Safety limits on the delivery amount may be included in the algorithm. The algorithm may be executed by a computing element within a process controller for controlling closed loop infusion formulation delivery. The biological state is sensed by a sensing device which provides a signal to the controller. The controller calculates an infusion formulation delivery amount based on the signal and sends commands to an infusion formulation delivery device which delivers an amount of infusion formulation determined by the commands.

Claims

1. A method for delivering an insulin formulation, the method comprising:

taking a plurality of samples of a blood glucose level over a period of time;

calculating a rate at which the blood glucose level of the plurality of samples is rising or falling over time;

comparing said calculated rate to a predefined threshold rate; and

disabling the delivery of the insulin formulation if the calculated rate is rising at a rate less than the predefined threshold rate, wherein the insulin formulation is delivered as a bolus.

2. The method recited in claim 1:

wherein each sample of the plurality of samples is taken at a time that is separated by a time period from a time at which a next sample or a previous sample was taken;

wherein a duration of said time period is selectively changeable.

3. The method recited in claim 1:

wherein, when the rate at which the calculated rate is rising is increasing over time, each sample of the plurality of samples is taken at a time that is separated by a first predefined time period from a time at which a next sample or a previous sample was taken;

wherein, when the rate at which the calculated rate is rising is decreasing over time, each sample of the plurality of samples is taken at a time that is separated by a second predefined time period from a time at which a next sample or a previous sample was taken; and

wherein the first predefined time period is different from the second predefined time period.

4. The method recited in claim 1:

wherein, when the rate at which the calculated rate is falling is increasing over time, each sample of the plurality of samples is taken at a time that is separated by a first predefined time period from a time at which a next sample or a previous sample was taken;

wherein, when the rate at which the calculated rate is falling is decreasing over time, each sample of the plurality of samples is taken at a time that is separated by a second predefined time period from a time at which a next sample or a previous sample was taken; and

wherein the first predefined time period is different from the second predefined time period.

5. The method recited in claim 1, wherein said amount of time between said plurality of samples of the blood glucose level is determined by linear regression or curve-fitting techniques.

6. The method recited in claim 1, further comprising:

disabling the delivery of the insulin formulation for a predefined amount of time from a time when a meal has been ingested.

7. The method recited in claim 1, further comprising:

detecting a biological state;

wherein the delivery of the insulin formulation is adjusted based on the biological state.

8. The method recited in claim 7, wherein the detected biological state comprises sleeping, being awake, temperature, exercising, or blood oxygen level.

9. The method recited in claim 1, further comprising:

disabling the delivery of the insulin formulation if an amount of insulin formulation delivered in a predefined time period is more than a predefined insulin formulation amount threshold.

10. A system for delivering an insulin formulation, the system comprising:

a data acquisition unit for taking a plurality of samples of a blood glucose level over a period of time;

a calculator for calculating a rate in which the blood glucose level of the plurality of the samples acquired by the data acquisition unit rises or falls over time;

a comparator for comparing said calculated rate to a predefined threshold rate; and

a controller for disabling the delivery of the insulin formulation if the calculated rate is rising at a rate less than the predefined threshold rate, wherein the insulin formulation is delivered as a bolus.

11. The system recited in claim 10:

wherein each sample of the plurality of samples is taken at a time that is separated by a time period from a time at which a next sample or a previous sample was taken;

wherein a duration of said time period is selectively changeable.

12. The system recited in claim 10:

wherein, when the rate at which the calculated rate is rising is increasing over time, each sample of the plurality of samples is taken at a time that is separated by a first predefined time period from a time at which a next sample or a previous sample was taken;

wherein, when the rate at which the calculated rate is rising is decreasing over time, each sample of the plurality of samples is taken at a time that is separated by a second predefined time period from a time at which a next sample or a previous sample was taken; and

wherein the first predefined time period is different from the second predefined time period.

13. The system recited in claim 10:

wherein, when the rate at which the calculated rate is falling is increasing over time, each sample of the plurality of samples is taken at a time that is separated by a first predefined time period from a time at which a next sample or a previous sample was taken and

wherein, when the rate at which the calculated rate is falling is decreasing over time, each sample of the plurality of samples is taken at a time that is separated by a second predefined time period from a time at which a next sample or a previous sample was taken; and

wherein the first predefined time period is different from the second predefined time period.

14. The system recited in claim 10, wherein an amount of time between said plurality of samples of the blood glucose level is determined by linear regression or curve-fitting techniques.

15. The system recited in claim 10, wherein the controller is further configured to disable the delivery of the insulin formulation for a predefined amount of time from a time when a meal has been ingested.

16. The system recited in claim 10, further comprising:

wherein the data acquisition unit is further configured to detect a biological state;

wherein said controller is further configured to adjust the delivery of the insulin formulation based on the biological state.

17. The system recited in claim 16, wherein the detected biological state comprises sleeping, being awake, temperature, exercising, or blood oxygen level.

18. The system recited in claim 10, wherein the controller is further configured to disable the delivery of the insulin formulation if an amount of insulin formulation delivered in a predefined time period is more than a predefined insulin formulation amount threshold.